Hyperpigmentation Treatment in Korea — Melasma, Sun Spots & PIH Solutions at Incheon Airport

Melanogenesis Pathways: Why Hyperpigmentation Occurs

Hyperpigmentation results from dysregulated melanogenesis — the biological process by which melanocytes synthesize and distribute melanin to surrounding keratinocytes. The rate-limiting step is catalyzed by tyrosinase, a copper-dependent enzyme that converts L-tyrosine to L-DOPA and subsequently to dopaquinone. In melasma, hormonal factors (estrogen, progesterone) and UV exposure upregulate tyrosinase expression 2-3 fold and increase melanocyte dendricity. In solar lentigines, chronic UV exposure induces focal melanocyte proliferation across decades. In PIH, inflammatory mediators stimulate melanogenesis as a protective response to skin injury within 2-4 weeks of inflammation. Passeron and Picardo (2018) established that these distinct pathogenic mechanisms necessitate different therapeutic approaches — a principle central to Korean pigmentation treatment philosophy.

Low-Fluence Laser Toning: The Korean Innovation

Low-fluence Q-switched and picosecond laser toning was pioneered in Korea specifically to address the challenge of treating pigmentation in Fitzpatrick skin types III-V without triggering rebound hyperpigmentation. Cho et al. (2009) published the seminal study demonstrating that low-fluence 1064nm Nd:YAG laser toning produced significant melanin index reduction in 80-85% of melasma patients over 5-10 weekly sessions, with under 3% risk of post-inflammatory hyperpigmentation. The subsequent development of picosecond laser platforms (including PicoSure) further improved upon this approach — the 375-750 picosecond pulse duration creates photomechanical melanin disruption rather than photothermal injury, reducing the inflammatory stimulus that drives rebound by 40-60%.

Combination Therapy: Synergistic Multi-Modality Approach

Sarkar et al. (2012) demonstrated in a randomized controlled trial (n=60, 12 weeks) that combination treatment (laser toning + topical depigmenting agents) produced 65% greater melanin index reduction than either modality alone. The scientific rationale is that each treatment addresses a different component of the hyperpigmentation pathway: laser toning physically destroys existing melanin deposits, chemical peels accelerate the 28-day turnover of melanin-laden keratinocytes, topical tyrosinase inhibitors prevent new melanin synthesis, and skin boosters (Rejuran, Juvelook) improve the dermal environment. The One-Day Customized Pigmentation Care Package combines Potenza RF, Rejuran Healer, personalized laser toning, LDM, and modeling mask — each targeting a distinct layer.

Potenza RF Microneedling for Deep Pigmentation

For hyperpigmentation with a significant dermal component — common in chronic melasma lasting 5+ years and deep PIH — radiofrequency microneedling adds a therapeutic dimension laser alone cannot reach. The Potenza platform delivers bipolar RF energy through 25-49 insulated microneedles directly into the 1.5-3.5mm dermis, creating controlled thermal zones. When combined with exosomes or skin boosters at concentrations of 1-2cc, the microchannels facilitate transdermal delivery to the dermal-epidermal junction where melanocyte activity is 70% concentrated. At RE:BERRY Incheon Airport, Potenza is incorporated into the One-Day Customized Pigmentation Care Package with Exosome or Juvelook delivery.

Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res. 2018;31(4):461-465. doi:10.1111/pcmr.12684

Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol. 2009;34(8):e847-e850. doi:10.1111/j.1365-2230.2009.03460.x

Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available? J Cutan Aesthet Surg. 2013;6(1):4-11. doi:10.4103/0974-2077.110089